cholangiocarcinoma of the extrahepatic bile duct
Showing 1 - 15 of 15
Recurrence After Whipple's (RAW) Study
Active, not recruiting
- Pancreatic Cancer
- +13 more
- Pancreaticoduodenectomy
-
Clayton, Victoria, Australia
- +28 more
Jan 13, 2023
Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Gallbladder, Adenocarcinoma of Unknown Primary Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +39 more
- oxaliplatin
- +4 more
-
Chicago, Illinois
- +1 more
May 7, 2020
EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice
Completed
- Pancreatic Cancer
- +3 more
- Endoscopic ultrasound
-
Bucharest, RomaniaGastroenterology Department, Clinical Hospital Colentina
Apr 26, 2020
Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer Trial in Shanghai (mutation and signal pathway activation
Unknown status
- Cholangiocarcinoma of the Extrahepatic Bile Duct
- Gallbladder Cancer
- mutation and signal pathway activation status analysis Drug: FORFIRINOX
-
Shanghai, Shanghai, ChinaXinhua Hospital
Dec 10, 2018
Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer Trial in Shanghai (conventional chemo(FORFIRINOX) combined
Unknown status
- Cholangiocarcinoma of the Extrahepatic Bile Duct
- Gallbladder Cancer
- conventional chemotherapy(FORFIRINOX) combined with target agents
- conventional chemotherapy(FORFIRINOX)
-
Shanghai, Shanghai, ChinaXinhua Hospital
Dec 6, 2018
Hepatocellular Carcinoma, Cholangiocellular Carcinoma, Cholangiocarcinoma of the Extrahepatic Bile Duct Trial in San Francisco,
Terminated
- Hepatocellular Carcinoma
- +6 more
- Cisplatin
- +2 more
-
San Francisco, California
- +1 more
Jun 27, 2018
Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer Trial in Shanghai (biological test, GEMOX, Cetuximab)
Unknown status
- Cholangiocarcinoma of the Extrahepatic Bile Duct
- Gallbladder Cancer
- biological test
- +8 more
-
Shanghai, Shanghai, ChinaXinhua Hospital
May 4, 2018
Adult Primary Cholangiocellular Carcinoma, Advanced Adult Primary Liver Cancer, Cholangiocarcinoma of the Extrahepatic Bile Duct
Terminated
- Adult Primary Cholangiocellular Carcinoma
- +10 more
- cediranib maleate
- +3 more
-
Cleveland, Ohio
- +6 more
Feb 10, 2017
Bile Duct Cancer, Intrahepatic Cholangiocarcinoma, Cholangiocarcinoma of the Extrahepatic Bile Duct Trial in Boston
Completed
- Bile Duct Cancer
- +2 more
-
Boston, Massachusetts
- +2 more
Dec 12, 2016
B-Receptor Signaling in Cardiomyopathy
Completed
- Carcinomas
- +37 more
-
Stanford, CaliforniaStanford University School of Medicine
Nov 16, 2015
Intrahepatic Cholangiocarcinoma, Cholangiocarcinoma of the Extrahepatic Bile Duct, Ampullary Carcinoma Trial in Beijing
Unknown status
- Intrahepatic Cholangiocarcinoma
- +3 more
- radioactive stent
- plastic stent
-
Beijing, Beijing, China307 hospital of PLA
Sep 10, 2014
Adult Primary Cholangiocellular Carcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer Trial in
Terminated
- Adult Primary Cholangiocellular Carcinoma
- +13 more
- ixabepilone
- laboratory biomarker analysis
-
Chicago, IllinoisUniversity of Chicago
May 13, 2014
Adult Primary Cholangiocellular Carcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer Trial in
Completed
- Adult Primary Cholangiocellular Carcinoma
- +10 more
- erlotinib hydrochloride
- laboratory biomarker analysis
-
Rochester, MinnesotaMayo Clinic
Jun 3, 2013
Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Unresectable Extrahepatic Bile Duct
Withdrawn
- Cholangiocarcinoma of the Extrahepatic Bile Duct
- +5 more
- porfimer sodium
- +4 more
-
Los Angeles, California
- +1 more
Apr 2, 2013
Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Adenocarcinoma With Squamous Metaplasia of the
Completed
- Adenocarcinoma of the Extrahepatic Bile Duct
- +9 more
- sorafenib tosylate
- laboratory biomarker analysis
-
San Antonio, TexasSouthwest Oncology Group
Jan 11, 2013